I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Etoposide is used as a inhibits DNA synthesis and is very active against cells in the late S and G2 phases of the cell cycle. Etoposide was reported to be used to serum starve Saos-2 M5(p53-/-) cells which were transfected by electroporation with indicated expression plasmids for flag-E2F1 and myc-EBNA3C for selection of colony forming units, thus studying the blocking effect of EBV Nuclear Antigen 3C on E2F1 Mediated Apoptosis Induced by the DNA Damage Response.
Hande, K.R. Etoposide: four decades of development of a topoisomerase II inhibitor.European Journal of Cancer.1998, (10), 1514-1521.
Maurice L. Slevin. The clinical pharmacology of etoposide.Supplement: Recent Advances in Etoposide Therapy Combined Proceedings of Two Symposia.1991, (1), 319-329.
Gefahrenhinweise (EU): H302-H350
Harmful if swallowed. May cause cancer.
Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.